SecBot SecBot
SECBOTREPLAY Home › Report › FBRX

FBRX · Forte Biosciences filed a universal shelf registration statement on…

Forte Biosciences, Inc. · S-3 filed Jun 2, 2026 at 16:39 ET

At the news

BEARISHIMPACT 6/10

S-3 filed Jun 2, 2026 at 16:39 ET

Forte Biosciences filed a universal shelf registration statement on Form S-3 to offer and sell up to $500,000,000 in securities (common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts, and units) from time to time. The company has a market cap of $342M, meaning the shelf represents ~146% of current market cap, signaling massive potential dilution. The filing is a placeholder, no specific offering is announced, but the company's cash burn is accelerating (Q1 2026 net loss of $22.1M vs $15.7M a year ago), and cash & equivalents fell from $77.0M to $58.2M in Q1 2026, suggesting the company will likely tap this shelf soon to fund operations.

  • Shelf registration for up to $500,000,000 in securities, ~146% of current $342M market cap
  • Cash & equivalents declined from $77.0M (Dec 2025) to $58.2M (Mar 2026)
  • Q1 2026 net loss of $22.1M vs $15.7M in Q1 2025, burn rate accelerating
  • Operating expenses rose 39% YoY to $22.4M, driven by R&D spend of $20.3M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access